The Global Clinical Trial & Supply Forum USA will take place on 24 - 25 March 2027 in Boston, United States.
Organised by BrainLinx, the Global Clinical Trial & Supply Forum USA 2027 brings together leaders from pharmaceutical and biotechnology companies, clinical research organisations, and specialist service providers to examine how trial design and supply decisions affect each other. The two-day programme follows the journey of investigational products from supply planning and packaging through distribution to clinical sites and patients.
On day one, sessions explore how patient recruitment, retention, and decentralised trial models shape demand forecasting and inventory decisions. Delegates will discuss how supply teams respond when enrolment differs from forecasts, coordinate deliveries across sites, and maintain product integrity throughout temperature-controlled distribution. The programme also covers direct-to-patient delivery, including how packaging, labelling, and logistics requirements change when medicines are shipped to participants’ homes.
Day two focuses on AI, automation, and predictive analytics in trial operations. Discussions will consider where real-time data can improve inventory visibility, flag potential shortages, and help teams respond to changing trial timelines. Sessions on global regulatory requirements, GxP standards, and quality systems will examine how sponsors, contract research organisations, manufacturers, and logistics partners share responsibility for managing risk across the trial lifecycle.
Keynote presentations, panel discussions, and one-to-one meetings give delegates opportunities to compare approaches to shared challenges and discuss requirements with potential partners. Clinical operations and supply leaders can evaluate solutions against the needs of their studies, while providers can hear directly from the teams responsible for forecasting, packaging, labelling, cold chain distribution, and digital systems about the problems they need to solve.
The forum is co-located with the Pharma Packaging & Labeling Innovation Forum 2027. The co-location gives participants an opportunity to discuss how packaging formats and label design affect product integrity, regulatory compliance, and usability for clinical site staff and trial participants. These conversations connect packaging decisions with the practical demands of running studies across multiple markets.